TLOG Projected Dividend Yield
TetraLogic Pharmaceuticals Corp ( OTCBB : TLOG )TetraLogic Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics in oncology, infectious diseases and autoimmune diseases. Co. has two clinical-stage product candidates in development: birinapant and suberohydroxamic acid 4-methoxycarbonyl phenyl ester (SHAPE). SHAPE is Co.'s proprietary histone deacetylase inhibitor that it is developing for topical use for the treatment of early-stage cutaneous T-cell lymphoma. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases, which causes apoptosis, or cell-death, in damaged cells. 20 YEAR PERFORMANCE RESULTS |
TLOG Dividend History Detail TLOG Dividend News TLOG Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |